As of 2026-03-14, the Intrinsic Value of Exelixis Inc (EXEL) is 52.52 USD. This EXEL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 41.24 USD, the upside of Exelixis Inc is 27.30%.
The range of the Intrinsic Value is 40.01 - 79.85 USD
Based on its market price of 41.24 USD and our intrinsic valuation, Exelixis Inc (EXEL) is undervalued by 27.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 40.01 - 79.85 | 52.52 | 27.3% |
| DCF (Growth 10y) | 49.82 - 96.43 | 64.56 | 56.5% |
| DCF (EBITDA 5y) | 44.76 - 61.41 | 52.59 | 27.5% |
| DCF (EBITDA 10y) | 54.29 - 76.86 | 64.56 | 56.5% |
| Fair Value | 72.97 - 72.97 | 72.97 | 76.94% |
| P/E | 26.15 - 73.04 | 51.95 | 26.0% |
| EV/EBITDA | 35.78 - 52.74 | 44.59 | 8.1% |
| EPV | 21.12 - 27.67 | 24.39 | -40.9% |
| DDM - Stable | 16.22 - 42.96 | 29.59 | -28.2% |
| DDM - Multi | 17.58 - 38.67 | 24.44 | -40.7% |
| Market Cap (mil) | 11,056.86 |
| Beta | 1.42 |
| Outstanding shares (mil) | 268.11 |
| Enterprise Value (mil) | 10,574.37 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.36% |
| Cost of Debt | 5.00% |
| WACC | 7.64% |